Atlas Trials

Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma

Clinical trial NCT01249066 · UNKNOWN

Trial details

NCT number
NCT01249066
Sponsor
China Medical University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Adenocarcinoma
Start date
2010-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.